A closer look at OA supplements—Part 2May 17, 2025In this installment, we will discuss green-lipped mussel, turmeric, undenatured collagen II, CBD products, and a recent literature review of each active nutraceutical.
SPONSORED CONTENTStart Treating Canine MMVD Patients at Stage B2Learn about early treatment with pimobendan for canine Stage B2 preclinical MMVD patients. + Learn More
Can CBD change drug levels in your patients?May 14, 2025Let’s see what the research says for three of the most popular conditions for which dogs receive CBD: seizure disorders, mobility disorders, and cancer.
VPN Plus+ ExclusiveA realistic approach to managing mastitisMay 6, 2025Blanket protocols for clinical mastitis treatment are still commonplace on many U.S. dairy farms. Putting more strategic treatment protocols in place with your dairy clients can deliver successful cow outcomes, reduce the costs associated with mastitis treatment, and lower the use of antimicrobials.
A One Health guide to preventativesApril 10, 2025Through a One Health lens, we evaluate the use of regular year-long preventives in dogs and cats, highlighting various available drug classes and options.
The expanding universe of canine aging scienceMarch 27, 2025In this exclusive feature, Dr. Brennen McKenzie explores the explosion of interest in canine geroscience and potential methods for extending healthy lifespan in dogs.
New study uses a supplement to decrease canine muscle lossMarch 27, 2025Check out the findings from a recent study demonstrating the safety and impact of ursolic acid supplementation in skeletal muscle mRNA expression and muscle function in dogs.
A closer look at OA supplements—Part 1March 15, 2025Osteoarthritis (OA) is common in dogs and cats. Often, the practitioner utilizes multimodal approaches to treatment, offering anti-inflammatory medications and dietary supplements. Let's look at some options for your OA patient.
VPN Plus+ ExclusiveThe Lyme-positive dog: Is it necessary to treat a blue dot?February 19, 2025So, do we treat all 9.55 percent that test positive, even if they are asymptomatic and testing confirms exposure but cannot tell us which ones will, if ever, develop clinical signs? That is a lot of antibiotics to doll out for often asymptomatic patients. Sadly, because the disease is not reportable in animals, we have a much less clear picture of the true incidence of clinical cases than in human medicine, which also has significant underreporting concerns.
The scoop on otitis externa medsFebruary 6, 2025Got a go-to plan for otitis externa cases? Instead of relying on "shotgun meds," learn a more precise approach to treatment. This feature walks through common scenarios to help you develop a targeted medical plan—reducing repeat cases and improving outcomes.
Best practices for pharmaceutical pain management with surgery for cats and dogsJanuary 14, 2025Streamlining pain control protocols can improve outcomes—this article highlights key options without overwhelming, ensuring happier patients and caregivers.
